Amsterdam, Netherlands : 13 - 16 March 2017
This conference is the second on this topic co-organised by the EACR and OECI. The conference will update you on advances in personalised cancer medicine, focusing on targeted and immunological therapeutic approaches. It will cover the challenges of tumour heterogeneity, drug resistance and the influence of the tumour microenvironment.
The programme will emphasise new in vitro and in vivo experimental models capturing the complexity of human tumours. New therapeutic targets will be discussed, including those from the metabolome and microenvironment. We will also give attention to how advances coming from the laboratory are being implemented in the clinic.
The programme includes plenary lectures and dedicated poster sessions, providing an excellent forum to share new data and to network with colleagues. Indeed, this conference will be limited to 120 participants, and speakers are invited to stay for the duration of the conference. There will be ample opportunity for networking and interaction, including a meet-the-speaker round table session.
The conference will bring together basic, translational and clinical scientists, as well as physicians engaged in the challenges of personalised medicine, the development of new therapeutics and clinical implementation.
Scientific Programme Committee: Daniel Peeper (chair), Richard Marais, Giorgio Stanta and Emile Voest
Making it Personal: Cancer Precision Medicine has been granted 14 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.